Trial CMRO

CMRO Mission Statement

To provide ethical, unbiased and rapid publication of quality content that is validated by rigorous peer review. CMRO's aim is to serve the information needs of the clinical medicine community, to help translate medical advances into patient care and be a leader in transparency/disclosure by facilitating a collaborative and honest approach to publication.

CMRO Scope

Current Medical Research & Opinion is a MEDLINE-indexed, peer-reviewed, international journal for the rapid publication of original research on new and existing drugs and therapies, Phase II-IV studies, and post-marketing investigations. Equivalence, safety and efficacy/effectiveness studies are especially encouraged. Preclinical, Phase I, pharmacoeconomic, outcomes and quality of life studies may also be considered if there is clear clinical relevance.

 

See Notes for Contributors for a fuller description of Aims and Scope and Types of Articles.

Submission and Publication Services

Publication in CMRO is entirely driven by editorial considerations and independent authoritative peer review. As part of our responsive approach to the rapid publication of clinical evidence, the journal offers two prioritized modes of publication and a third, non-prioritized mode.

  • FastTrack: This offers the most highly prioritised service, with a submission to online publication timeline of 5-7 weeks (subject to 1-2 week author revision following initial peer-review and prompt turnaround of proofs). There is a publication support fee for this expedited service, based on a charge of $825/£450/€675 per published page. This charge supports the expedient processing of material and includes 20 tokens for downloading full text of the article published online.
  • RapidTrack: This prioritised service offers submission to online publication in 10-12 weeks and is subject to a publication support fee of $375/£205/€305 per page; 10 download tokens also are provided as an additional service of this service.
  • StandardTrack: This non-prioritised standard service provides submission to online publication up to 16 weeks; there are no publication support fees charged for this mode.

For fuller submission information, please see the Notes for Contributors.

Pre-submission Contact

CMRO encourages authors to contact the Editorial Office ahead of formal submission and specially recommends prior contact for FastTrack and RapidTrack submissions where a particular publication deadline is desired. Please see Editorial Office contact details. CMRO also welcomes contact on special projects, including supplement issues and advance orders of printed reprints, ePrints and web links.

Online and Print Publication

CMRO is published continuously online. All articles are first published online on the CMRO EarlyOnline platform, followed by print and electronic publication in one of the 12 published issues per year. EarlyOnline articles have final pagination as well as DOI information, are immediately citable and are made available as Epub ahead of print entries on PubMed. Articles appear in print and electronic issues 2-6 weeks later from Early Online publication. Articles published in the electronic issues are available in xml full text, PDF or PDF Plus (with CrossRef citation linking).

How to Submit

Editorial correspondence and submissions (manuscripts and accompanying files) should be addressed to the Editorial Office as given below and sent via email to: info@cmrojournal.com.

For full details on how to prepare material for submission (including covering correspondence and acceptable files), please refer to the latest Notes for Contributors.

Or contact:

 

Dorothy Pennachio, Executive Managing Editor,

CMRO/Informa,

52 Vanderbilt Avenue, 7th Floor, New York, NY 10017, USA.

E-mail: dpennachio@cmrojournal.com

Tel.: +1 212 520 2759; Fax: +1 201 794-6040.

 

Kester Müller, Assistant Editor,

CMRO/Informa Healthcare,

Telephone House, 69-77 Paul Street, London EC2A 4LQ, UK.

E-mail: kmuller@cmrojournal.com

Tel.: +44 20 3377 3208; Fax: +44 20 7017 7831.

Indexing

Indexed / abstracted in MEDLINE / PubMed and EMBASE / Excerpta Medica, Current Contents / Clinical Medicine, Science Citation Index and ISI Web Of Knowledge and in the following databases: Adis Clinical Trials Insight, CA Search/CAS Online, CAB Abstracts, CancerLit, Derwent Drug File, HEED/Health Economic Evaluations Database, International Pharmaceutical Abstracts, NLM Gateway, Pascal, Pharm-line, PsycINFO, SciSearch, Science Citation Index Expanded (Web of Science), SIIC and TOXFILE/Toxline.

Publication Impact Factors

5-Year ISI Impact Factor (2008): 2.866

CMRO is ranked 27/107 in the Medicine, General & Internal category in the 2008 ISI Journal Citation Reports and 32/82 in the Medicine, Research & Experimental category.

Publication Information

  • Founded in 1972
  • ISSN: Online eISSN: 1473-4877
  • Print Frequency: 12 issues per year plus supplements.

Editorial Contacts

For all general editorial and submission enquiries please email: info@cmrojournal.com or refer to the latest Notes for Contributors

 

Publisher: Jay Magrann

Executive Managing Editor (New York): Dorothy Pennachio

Editorial Assistant (London): Kester Muller

Other contacts

Editorial Advisory Boards

Overseeing the editorial content and development of the journal are Editorial Boards of international leading experts in clinical research and pharmaceutical medicine.

For information about the Editorial Board please click here.

Policies

Transparency Policy

CMRO supports and follows the various good publishing practice guidelines and initiatives promulgated by such organizations as ICMJE, ISMPP, COPE, NLM and others that encourage transparency/disclosure of financial relationships with industry.

In an effort to provide transparency beyond those recommended by the aforementioned organizations, CMRO will ensure that any person in a position to influence the content of the journal provides a formal statement of relevant financial or other relationships with commercial entities and may lead to a real or perceived conflict of interest. These financial relationships shall be disclosed to CMRO's readers in print and/or on the CMRO web site.

 

The full transparency policy is available here >>

 

Plagiarism

CMRO has a strict policy against plagiarism. We define plagiarism as the use of extracts from another person's work that are not placed in quotation marks, without the permission of that person, and without acknowledgement to that person (using the appropriate reference style), with the result that your article presents these extracts as original to you. By submitting your work to an Informa journal, you warrant that it is your original work, and that you have secured the necessary written permission from the appropriate copyright owner or authority for the reproduction of any text, illustration, or other material.

If any article submitted to CMRO is found to have breached any of these conditions, CMRO reserves the right to reject that article and any others submitted by the same authors. CMRO may also contact the authors' affiliated institutions to inform them of its findings.

Reprints and Post-publication Services

Reprints are available both in print and electronically, in US and European formats and with or without covers. Contact Jenn Kane at jenn.kane@informa.com for further details.

Printed

  • Without covers
    The first page of text of the paper is the first page of the reprint.
  • Cover Options
    Self covers (Black & White title page)
  • Our standard cover design is printed in black and white on the same type of paper as the reprint.
    In cases where there are two or more blank pages available there may be no extra charge for this.
  • Color covers
    Our standard color cover design in two colours is printed on heavier weight paper and bound to the reprint.

Formats

There is a choice of 8.5 x 11 inch or A4 format.

For reprints produced in the USA for delivery in the Americas, 8.5 x 11 inch is the usual format.

For reprints produced elsewhere, A4 is the usual format.

Electronic Options

Customised online ePrint service. We can host a PDF file of a reprint on our server and provide a secure link to it from another website. Page views are bought in advance and can be renewed. Please contact us for further details.

Licensed PDFs subject to agreement: we can provide a PDF file of a reprint for use on CDs and other media.

Additional Services and Special Requirements

  • Customized information, subject to approval.
  • Examples include:
    - Disclaimers, product and regulatory Information
    - Codes
    - Logos

 

Subject to the space available these can be printed in black or the same color as the color covers. There is normally no extra charge.

 

Advertisements are subject to copy approval and may incur an additional cost.

Translations

We can have papers translated into almost any other language and reprinted as detailed above.

Obtaining a Quotation

We will normally provide you with a quotation within 1 working day of the request. To help us expediate your request, please provide us with the following information:

  • Your full company address
  • The full citation - journal, volume, page numbers, title, author
  • The quantities you require us to quote for, with or without covers and any format requirements (see above)
  • Where you want the reprints shipped
  • Any other special requirements, such as codes and disclaimers

 

For reprint quotations, please contact Jenn Kane at jenn.kane@informausa.com

Supplements

CMRO is amenable to the publication of supplements with the journal. These can include conference reports, proceedings of meetings, workshops, webcasts, and single drug and therapeutic reviews. All supplements are published through our RapidTrack service, which provides for online publication in 10-12 weeks from formal submission; supplements can be made available with free online access for various periods of time, subject to an agreed fee. Supplements can be mailed externally with an issue of CMRO (via polybags), as an in-journal supplement that is contained within the journal itself, or as an online copy. Additional distribution formats and services are offered. To help ensure that supplements are free from promotion, all supplement content undergoes CMRO's standard, rigorous peer-review process.

 

For supplement quotations or questions, please contact Yvonne Oliver at yvonne.oliver@informa.com

Permissions

Material published by CMRO is protected under international copyright law.

 

Written authorization is required to reproduce any of our material. For non-commercial/scholarly reproduction of small amounts of material such as figures and tables we normally do not charge a fee but written permission is still necessary from us. For commercial requests, a permission fee payment may be necessary. Please be advised that we may not be the copyright holder of the material you wish to use, even if the work was published by us.

 

Check the original source of the material carefully in the references.

 

When placing your request with us, ideally by email, please include the following information:

  • The full reference of the article from which the material will be taken
  • Exactly what material you wish to use and what the use is, including approximate distribution quantities
  • What the territories for distribution of the material are

CMRO publications are registered with the Copyright Licensing Agency in the UK and the Copyright Clearance Center in the USA for the limited copying of material for personal, classroom, academic and commercial purposes.

 

For permissions requests, please email us at info@cmrojournal.com

Subscriptions

Click here for subscription rates to CMRO and other Informa Healthcare Journals.

 

For information about subscriptions, please contact:

Scott Magrowski at scott.magrowski@informa.com or Imran Khan at imran.khan@informa.com